Atypical antipsychotics, which are used as a treatment for both MDD and bipolar disorder, have also been shown to decrease levels of TNF-α and IL-6 in animal models (Bian et al., 2008; Kato et al., 2007). This evidence concerns the gene IL6 and bipolar disorder.